Evidence map›Paper›PMID 36946054›Full record

ArticleNan fang yi ke da xue xue bao = Journal of Southern Medical University2023

[Serum lipoprotein-associated phospholipase A2 level is positively correlated with the recurrence risk of acute ischemic cerebral infarction in hypertensive patients].

L Liang, J Chen, C Zhang, Y Wang, B Luo, T Zhou, X Wang

Open access · greenAbstract readEnglish Abstract
In one paragraph

Article in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

L LiangDepartment of Neurology, The Third Affiliated Hospital of Southern Medical University, Guangzhou 510630, China.
J ChenDepartment of Neurology, The Foshan First People's Hospital, Foshan 528000, China.
C ZhangDepartment of Neurology, The Foshan First People's Hospital, Foshan 528000, China.
Y WangDepartment of Neurology, The Foshan First People's Hospital, Foshan 528000, China.
B LuoScience and Education Department, The Foshan First People's Hospital, Foshan 528000, China.
T ZhouDepartment of Emergency Medicine, The Foshan First People's Hospital, Foshan 528000, China.
X WangDepartment of Neurology, The Third Affiliated Hospital of Southern Medical University, Guangzhou 510630, China.
Third Affiliated Hospital of Southern Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo explore the relationship between serum lipoprotein-associated phospholipase A2 (Lp-PLA2) level and the risk of acute ischemic stroke (AIS) recurrence in hypertensive patients.

methodsThis retrospective case-control study was conducted among 211 hypertensive patients with AIS treated in Foshan First People's Hospital, including 35 patients with recurrence of AIS during the 1-year follow-up as confirmed by head CT/MR. In the overall patients, 60 had grade 1 hypertension (including 5 recurrent cases), 76 had grade 2 hypertension (with 11 recurrent cases), and 75 had grade 3 hypertension (with 19 recurrent cases). Univariate analysis, multivariate logistic regression analysis, trend analysis, and smooth curve fitting analysis were performed to explore the correlation between serum Lp-PLA2 level within 24 h after admission and the risk of AIS recurrence. The predictive efficacy of serum Lp-PLA2 level for AIS recurrence in different hypertension grades was evaluated using ROC curve analysis.

resultsSerum Lp-PLA2 level, age, NIHSS score at admission, mRS scores at 7 days, homocysteine level and smoking status differed significantly between patients with and without AIS recurrence (

conclusionSerum Lp-PLA2 concentration is an independent risk factor and potentially an effective predictor for AIS recurrence in patients with grade 3 hypertension.

Indexed as

Brain IschemiaHypertensionIschemic StrokeStroke1-Alkyl-2-acetylglycerophosphocholine EsteraseAcute DiseaseBiomarkersCase-Control StudiesCerebral InfarctionHumansInfant, NewbornRetrospective StudiesRisk Factors1-Alkyl-2-acetylglycerophosphocholine EsteraseBiomarkersPLA2G7 protein, humancorrelation analysisischemic stroke with hypertensionlipoprotein-associated phospholipase A2recurrence

Identifiers

PMID36946054
PMCPMC10034551
OpenAlexW4353020344

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.